Sort
51,593 grants matching “hepatitis”
Jagged-Notch signaling in NASH/fibrosis
$417,994Utpal Pajvani · Columbia University Health Sciences · R01 · FY2020 · DK
Mechanism Of Interferon Induction By The Hepatitis C Virus
$417,992Francis Vincent Chisari · University Of Washington · U19 · FY2011 · AI
Treating AT Deficiency with Drugs that Modulate the Proteostasis Network
$417,961David H Perlmutter · Washington University · P01 · FY2021 · DK
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$417,897Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2025 · DK
The Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease
$417,866Jeffrey D Browning · Ut Southwestern Medical Center · R01 · FY2012 · DK
Development of Polarity in Hepatic Cells
$417,855Ann L Hubbard · Johns Hopkins University · R01 · FY2006 · DK
Predicting glymphatic function via PET/MR imaging biomarkers and Nose to Brain contrast delivery
$417,853Kurt R Zinn · Michigan State University · R21 · FY2022 · AG
Biobehavioral pathways linking stress and cancer progression
$417,819Jennifer L. Steel · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
Biological Markers of Aflatoxin Exposure and Methylation
$417,806Regina M Santella · Columbia University Health Sciences · R01 · FY2011 · ES
Viral Host Interactions in Hepatitis C
$417,803David Richard Gretch · University Of Washington · R01 · FY2009 · AI
HCV Disease Management in HIV- HCV Coinfected IDUs
$417,799Mark Sebastian Sulkowski · Johns Hopkins University · R01 · FY2011 · DA
CLINICAL AND BIOLOGICAL BASIS OF 18F-FDG PET IN CANCER
$417,761Sloan-Kettering Institute For Cancer Res · R01 · FY2000 · CA
Control of Lipogenesis and Hepatic Steatosis by Caspase-2
$417,724Michael Karin · University Of California, San Diego · R01 · FY2022 · DK
Chip Based Diagnosis of Problematic Liver Tumors
$417,714Timothy J Yeatman · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Low Cost Multi-pathogen Laser Diagnostic for HIV and AIDS Co-Infections
$417,713Christopher John Myatt · Precision Photonics Corporation (Ppc) · R44 · FY2007 · AI
HEPATITIS C VIRUS IMMUNOBIOLOGY AND PATHOGENESIS
$417,683Scripps Research Institute · R01 · FY2000 · CA
Non-beta-lactam GLT-1 activators: characterization in preclinical models of opioid and cocaine addiction
$417,646Scott M Rawls · Temple Univ Of The Commonwealth · R01 · FY2021 · DA
Investigation of the mechanism by which NPC1 dysfunction leads to liver disease
$417,622Laura Liscum · Tufts University Boston · R01 · FY2012 · DK
Investigation of the mechanism by which NPC1 dysfunction leads to liver disease
$417,622Laura Liscum · Tufts University Boston · R01 · FY2011 · DK
Novel roles of copper in adaptive responses to hypoxia
$417,616Michael J Petris · University Of Missouri-Columbia · R01 · FY2024 · DK
Promoting Hepatitis B Screening for Vietnamese American Adults
$417,593Tung T Nguyen · University Of California At Davis · P01 · FY2009 · CA
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$417,565Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Development and application of non-thermal high frequency IRE to treat hepatic tumors
$417,562Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · CA
Development and application of non-thermal high frequency IRE to treat hepatic tumors
$417,538Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · CA
Retroviral Coded Functions
$417,529Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA